Table 1.
Experimental Group | Treatment | |||
---|---|---|---|---|
TPA Only | DMBA Only | DMBA+TPA | No Treatment | |
ROSA26-LSL-MCPyV168 | 17 | 22 (18) | 23 (19) | 0 |
K14Cre-MCPyV168 | 12 | 14 | 17 (16) | 28 (22) |
K14E6/E7 | 13 | 10 | 22 (16) | 0 |
Experimental Group | Treatment | |||
---|---|---|---|---|
TPA Only | DMBA Only | DMBA+TPA | No Treatment | |
ROSA26-LSL-MCPyV168 | 17 | 22 (18) | 23 (19) | 0 |
K14Cre-MCPyV168 | 12 | 14 | 17 (16) | 28 (22) |
K14E6/E7 | 13 | 10 | 22 (16) | 0 |